tiprankstipranks
Advertisement
Advertisement

HK:2595 Stock Latest News

GenFleet Tightens Audit Committee Charter to Bolster Governance
Company AnnouncementsGenFleet Tightens Audit Committee Charter to Bolster Governance
2d ago
2595
GenFleet Tightens Remuneration Committee Mandate to Bolster Governance
PremiumCompany Announcements
GenFleet Tightens Remuneration Committee Mandate to Bolster Governance
2d ago
2595
GenFleet Tightens Board Nomination Rules to Strengthen Governance
PremiumCompany Announcements
GenFleet Tightens Board Nomination Rules to Strengthen Governance
2d ago
2595
GenFleet Therapeutics Narrows Adjusted Loss and Bolsters Cash as 2025 Results Released
PremiumCompany Announcements
GenFleet Therapeutics Narrows Adjusted Loss and Bolsters Cash as 2025 Results Released
2d ago
2595
GenFleet to Showcase RAS-Targeted Preclinical Data at 2026 AACR Meeting
PremiumCompany Announcements
GenFleet to Showcase RAS-Targeted Preclinical Data at 2026 AACR Meeting
7d ago
2595
GenFleet Therapeutics Sets March Board Meeting to Approve 2025 Results and Consider Dividend
PremiumCompany AnnouncementsGenFleet Therapeutics Sets March Board Meeting to Approve 2025 Results and Consider Dividend
15d ago
2595
GenFleet Therapeutics to Join Stock Connect and Key Hang Seng Indexes in 2026
Premium
Company Announcements
GenFleet Therapeutics to Join Stock Connect and Key Hang Seng Indexes in 2026
18d ago
2595
GenFleet Wins China Breakthrough Therapy Nod for KRAS G12D Lung Cancer Drug
Premium
Company Announcements
GenFleet Wins China Breakthrough Therapy Nod for KRAS G12D Lung Cancer Drug
25d ago
2595
GenFleet Added to Hang Seng and MSCI Indexes, Boosting Market Profile
PremiumCompany Announcements
GenFleet Added to Hang Seng and MSCI Indexes, Boosting Market Profile
1M ago
2595
GenFleet Shareholders Approve Incentive Schemes and Governance Overhaul at EGM
PremiumCompany Announcements
GenFleet Shareholders Approve Incentive Schemes and Governance Overhaul at EGM
2M ago
2595
GenFleet Therapeutics Calls EGM to Approve New H-Share Incentive Plans, Buy-back Mandate and Governance Changes
PremiumCompany Announcements
GenFleet Therapeutics Calls EGM to Approve New H-Share Incentive Plans, Buy-back Mandate and Governance Changes
2M ago
2595
GenFleet Overhauls Governance Structure, Calls EGM for Key Incentive and Capital Measures
PremiumCompany Announcements
GenFleet Overhauls Governance Structure, Calls EGM for Key Incentive and Capital Measures
2M ago
2595
GenFleet Therapeutics Launches Pioneering Phase III Study for Pancreatic Cancer Treatment
PremiumCompany AnnouncementsGenFleet Therapeutics Launches Pioneering Phase III Study for Pancreatic Cancer Treatment
4M ago
2595
GenFleet Therapeutics Proposes New Share Incentive Schemes
Premium
Company Announcements
GenFleet Therapeutics Proposes New Share Incentive Schemes
4M ago
2595
GenFleet Therapeutics Initiates Phase Ib/II Study of GFH375 for Advanced Solid Tumors
Premium
Company Announcements
GenFleet Therapeutics Initiates Phase Ib/II Study of GFH375 for Advanced Solid Tumors
5M ago
2595
GenFleet Therapeutics Updates Articles of Association Following Capital Increase
PremiumCompany Announcements
GenFleet Therapeutics Updates Articles of Association Following Capital Increase
5M ago
2595
GenFleet Therapeutics Reports Promising Trial Results for KRAS G12D Inhibitor in Pancreatic Cancer
PremiumCompany Announcements
GenFleet Therapeutics Reports Promising Trial Results for KRAS G12D Inhibitor in Pancreatic Cancer
5M ago
2595
GenFleet Therapeutics Completes Over-Allotment Option and Prepares for HKEX Listing
PremiumCompany Announcements
GenFleet Therapeutics Completes Over-Allotment Option and Prepares for HKEX Listing
5M ago
2595
GenFleet Therapeutics Advances RAS-Targeted Therapy with GFH276 Trial
PremiumCompany Announcements
GenFleet Therapeutics Advances RAS-Targeted Therapy with GFH276 Trial
6M ago
2595

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >